fluorodeoxyglucose f18 has been researched along with isoleucine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belichenko, NP; Chin, FT; Condon, C; James, ML; Kuan, J; Longo, FM; Miao, Z; Semaan, S; Shuhendler, AJ; Simmons, DA | 1 |
| Goh, HJ; Goh, JP; Govindharajulu, P; Henry, CJ; Leow, MK; Michael, N; Sadananthan, SA; Sun, L; Velan, SS; Verma, S | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and isoleucine
| Article | Year |
|---|---|
Brown adipose tissues mediate the metabolism of branched chain amino acids during the transitioning from hyperthyroidism to euthyroidism (TRIBUTE).
Topics: Adipose Tissue, Brown; Amino Acids, Branched-Chain; Fluorodeoxyglucose F18; Humans; Hyperthyroidism; Insulin; Insulin Resistance; Isoleucine; Leucine; Valine | 2022 |
1 other study(ies) available for fluorodeoxyglucose f18 and isoleucine
| Article | Year |
|---|---|
TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
Topics: Animals; Cerebral Cortex; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Huntington Disease; Isoleucine; Male; Mice; Microglia; Morpholines; Positron-Emission Tomography; Protein Binding; Receptors, GABA; Receptors, Nerve Growth Factor | 2018 |